BeyondSpring Inc (BYSI)

NASDAQ
0.60
0.00(0.60%)
Pre Market
0.60
0.00(-0.15%)
- Real-time Data
  • Volume:
    175,417
  • Day's Range:
    0.55 - 0.60
  • 52 wk Range:
    0.55 - 14.64
Trading near 52-week Low

BeyondSpring has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

BYSI Overview

Prev. Close
0.6
Day's Range
0.55-0.6
Revenue
680K
Open
0.59
52 wk Range
0.55-14.64
EPS
-1.64
Volume
175,417
Market Cap
23.36M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
109,387
P/E Ratio
-
Beta
1.13
1-Year Change
-95.82%
Shares Outstanding
38,927,563
Next Earnings Date
Dec 22, 2022
What is your sentiment on BeyondSpring?
or
Market is currently closed. Voting is open during market hours.

BeyondSpring Inc News

BeyondSpring Inc Analysis

BeyondSpring Inc Company Profile

BeyondSpring Inc Company Profile

Employees
103

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company’s lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

Read More

Analyst Price Target

Average2.30 (+283.33% Upside)
High2.3
Low2.3
Price0.6
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell
  • $70s incoming
    2
    • I was right. Yay me.
      0
      • here we go. ride the wave, in with 1000 shares at 9.56
        0
    • Another pump n dump. Everyones chasing the next med stock in hopes of ending the covidnoia It's not going to happen. Covid is a tool the corrupt governments have now to control the people and they'll never give it up. It's how they'll rig the 2022 mid term as well.
      8
      • Nison KayUganda??
        0
      • Uruguay??
        0
      • This has nothing to do with covid you paranoid conspirim o r. on
        0
    • what's going on  is it stuck on 24.59?
      1
      • Halted due to volatility. Resumed trading though and climbing. =)
        0
    • HC Wainwright & Co upgrades BYSI on trial results news and sets PT of $100
      0
      • "shorty get down, good lord" music quotes that make a lot of sense rn
        0
        • :) who buy from here lol stupid pre market
          0
          • Real PT of $25EOY and PT of $200 if an acquisition comes in. It's at the bottom right now at 10.60. BUY
            1